MRSA, VRE, KPC, ESBL multiple drug resistant organism are showing up in healthcare facilities and in the community. What do you need to know?
FDA currently reviewing the ability of VESTEX® to reduce COVID-19. While the FDA has not yet reviewed the ability of products protected by VESTEX® to reduce COVID-19, preliminary research has documented results […]
Don’t risk taking body fluids, bacteria or viruses home anymore. VESTEX is the company to go to. They are approved by the FDA and work the way advertise. They are […]
https://www.infectioncontroltoday.com/view/how-infection-preventionists-or-nurses-work-better-together
Author – John Jernigan, M.D., director of CDC’s Office of Prevention Research and Evaluation and head of CDC’s Prevention Epicenters Program. I am excited to announce the results of the REDUCE MRSA study which evaluated three current strategies f…
Susan Huang, M.D., M.P.H., lead author of the REDUCE MRSA study and Associate Professor at the University of California Irvine School of Medicine and Medical Director of Epidemiology and Infection Prevention at UC Irvine Health For years, we have searc…
The REDUCE MRSA trial was published in today’s New England Journal of Medicine and took place in two stages from 2009-2011. A multidisciplinary team from the University of California, Irvine, Harvard Pilgrim Health Care Institute, Hospital Corporatio…
Author: John Jernigan, M.D Director for CDC’s Office of HAI Prevention Research and Evaluation, Division of Healthcare Quality Promotion The optimal approach to controlling MRSA in healthcare facilities has been a topic of ongoing controversy. Of par…
Colonization vs Infection Colonization is the presence, growth, and multiplication of the organism without observable clinical symptoms or immune reaction. 1. MRSA – Colonization may occur in: the nares; […]
Gram-negative bacilli have been a source of healthcare-associated infections for many years and may be found in patients in virtually all healthcare settings as either infection or colonization. In […]
Vancomycin-resistant enterococci were initially reported in 1986 in Europe. In the last two decades enterococci have become recognized as a leading cause of healthcare associated bacteremia, surgical wound infection, and […]
Methicillin-resistant S. aureus is a variant of S. aureus which is considered to be resistant to all beta-lactam antibiotics (including penicillins, cephalosporins, and cephamicins). It may also be resistant to […]
Community-Associated MRSA has emerged in the general population as a frequent cause of skin infections (boils, abscesses, furuncles, etc.), and occasionally more invasive infections in healthy individuals lacking the usual […]
August 11,2010 Jama reported that from 2005 through 2008, there were 21503 episodes of invasive MRSA infections; 17508 were health care associated. Of these, 15,458 were MRSA bloodstream infections. The […]